HIV-1 Vpr activates both canonical and noncanonical NF-κB pathway by enhancing the phosphorylation of IKKα/Β

Virology

Volumn 439, Issue 1, 2013, Pages 47-56

  Liu, Ruikang ^a   Tan, Juan ^a   Lin, Yongquan ^a   Jia, Rui ^a   Yang, Wei ^a   Liang, Chen ^b,c   Geng, Yunqi ^a   Qiao, Wentao ^a  

^a NANKAI UNIVERSITY   (China)

^b MCGILL UNIVERSITY   (Canada)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

IKK ; NF B; Phosphorylation; Viral protein R (Vpr)

Indexed keywords

I KAPPA B ALPHA; I KAPPA B KINASE ALPHA; I KAPPA B KINASE BETA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN P100; SYNAPTOTAGMIN I; VPR PROTEIN;

ARTICLE; CONTROLLED STUDY; EMBRYO; ENZYME PHOSPHORYLATION; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; IN VIVO STUDY; LONG TERMINAL REPEAT; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION;

CELL LINE; HIV-1; HUMANS; I-KAPPA B KINASE; NF-KAPPA B; NUCLEAR PROTEINS; PHOSPHORYLATION; PROTEIN INTERACTION MAPPING; PROTEIN PROCESSING, POST-TRANSLATIONAL; SIGNAL TRANSDUCTION; VIRUS REPLICATION; VPR GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 84874996875     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2013.01.020     Document Type: Article

References (53)

1. Agostini I., Popov S., Hao T., Li J.H., Dubrovsky L., Chaika O., Chaika N., Lewis R., Bukrinsky M. Phosphorylation of Vpr regulates HIV type 1 nuclear import and macrophage infection. AIDS Res. Hum. Retroviruses 2002, 18(4):283-288.
2. Amir R.E., Haecker H., Karin M., Ciechanover A. Mechanism of processing of the NF-kappa B2 p100 precursor: identification of the specific polyubiquitin chain-anchoring lysine residue and analysis of the role of NEDD8-modification on the SCF(beta-TrCP) ubiquitin ligase. Oncogene 2004, 23(14):2540-2547.
3. Asin S., Bren G.D., Carmona E.M., Solan N.J., Paya C.V. NF-kappaB cis-acting motifs of the human immunodeficiency virus (HIV) long terminal repeat regulate HIV transcription in human macrophages. J. Virol. 2001, 75(23):11408-11416.
4. Barnitz R.A., Wan F., Tripuraneni V., Bolton D.L., Lenardo M.J. Protein kinase A phosphorylation activates Vpr-induced cell cycle arrest during human immunodeficiency virus type 1 infection. J. Virol. 2010, 84(13):6410-6424.
5. Bren G.D., Trushin S.A., Whitman J., Shepard B., Badley A.D. HIV gp120 induces, NF-kappaB dependent, HIV replication that requires procaspase 8. PLoS One 2009, 4(3):e4875.
6. Chen G., Cao P., Goeddel D.V. TNF-induced recruitment and activation of the IKK complex require Cdc37 and Hsp90. Mol. Cell 2002, 9(2):401-410.
7. Cohen E.A., Dehni G., Sodroski J.G., Haseltine W.A. Human immunodeficiency virus vpr product is a virion-associated regulatory protein. J. Virol. 1990, 64(6):3097-3099.
8. Dejardin E. The alternative NF-kappaB pathway from biochemistry to biology: pitfalls and promises for future drug development. Biochem. Pharmacol. 2006, 72(9):1161-1179.
9. Dejardin E., Droin N.M., Delhase M., Haas E., Cao Y., Makris C., Li Z.W., Karin M., Ware C.F., Green D.R. The lymphotoxin-beta receptor induces different patterns of gene expression via two NF-kappaB pathways. Immunity 2002, 17(4):525-535.
10. Demarchi F., Gutierrez M.I., Giacca M. Human immunodeficiency virus type 1 tat protein activates transcription factor NF-kappaB through the cellular interferon-inducible, double-stranded RNA-dependent protein kinase, PKR. J. Virol. 1999, 73(8):7080-7086.
11. Diao L., Zhang B., Fan J., Gao X., Sun S., Yang K., Xin D., Jin N., Geng Y., Wang C. Herpes virus proteins ICP0 and BICP0 can activate NF-kappaB by catalyzing IkappaBalpha ubiquitination. Cell Signal 2005, 17(2):217-229.
12. Douek D.C., Roederer M., Koup R.A. Emerging concepts in the immunopathogenesis of AIDS. Annu. Rev. Med. 2009, 60:471-484.
13. Ducut Sigala J.L., Bottero V., Young D.B., Shevchenko A., Mercurio F., Verma I.M. Activation of transcription factor NF-kappaB requires ELKS, an IkappaB kinase regulatory subunit. Science 2004, 304(5679):1963-1967.
14. Duverger A., Jones J., May J., Bibollet-Ruche F., Wagner F.A., Cron R.Q., Kutsch O. Determinants of the establishment of human immunodeficiency virus type 1 latency. J. Virol. 2009, 83(7):3078-3093.
15. Fortin J.F., Barat C., Beausejour Y., Barbeau B., Tremblay M.J. Hyper-responsiveness to stimulation of human immunodeficiency virus-infected CD4+T cells requires Nef and Tat virus gene products and results from higher NFAT, NF-kappaB, and AP-1 induction. J. Biol. Chem. 2004, 279(38):39520-39531.
16. Gummuluru S., Emerman M. Cell cycle- and Vpr-mediated regulation of human immunodeficiency virus type 1 expression in primary and transformed T-cell lines. J. Virol. 1999, 73(7):5422-5430.
17. Hacker H., Karin M. Regulation and function of IKK and IKK-related kinases. Sci. STKE 2006, 2006(357):re13.
18. Hayden M.S., Ghosh S. Signaling to NF-kappaB. Gene. Dev. 2004, 18(18):2195-2224.
19. Hoshino S., Konishi M., Mori M., Shimura M., Nishitani C., Kuroki Y., Koyanagi Y., Kano S., Itabe H., Ishizaka Y. HIV-1 Vpr induces TLR4/MyD88-mediated IL-6 production and reactivates viral production from latency. J. Leukoc. Biol. 2010, 87(6):1133-1143.
20. Iijima S., Nitahara-Kasahara Y., Kimata K., Zhong Zhuang W., Kamata M., Isogai M., Miwa M., Tsunetsugu-Yokota Y., Aida Y. Nuclear localization of Vpr is crucial for the efficient replication of HIV-1 in primary CD4+ T cells. Virology 2004, 327(2):249-261.
21. Ishii T., Kwon H., Hiscott J., Mosialos G., Koromilas A.E. Activation of the I kappa B alpha kinase (IKK) complex by double-stranded RNA-binding defective and catalytic inactive mutants of the interferon-inducible protein kinase PKR. Oncogene 2001, 20(15):1900-1912.
22. Jacquot G., Le Rouzic E., David A., Mazzolini J., Bouchet J., Bouaziz S., Niedergang F., Pancino G., Benichou S. Localization of HIV-1 Vpr to the nuclear envelope: impact on Vpr functions and virus replication in macrophages. Retrovirology 2007, 4:84.
23. Karin M., Ben-Neriah Y. Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity. Annu. Rev. Immunol. 2000, 18:621-663.
24. Kogan M., Deshmane S., Sawaya B., Gracely E.J., Khalili K., Rappaport J. Inhibition of NF-kappaB activity by HIV-1 Vpr is dependent on Vpr binding protein. J. Cell Physiol. 2012.
25. Kucharczak J., Simmons M.J., Fan Y., Gelinas C. To be, or not to be: NF-kappaB is the answer-role of Rel/NF-kappaB in the regulation of apoptosis. Oncogene 2003, 22(56):8961-8982.
26. Levy D.N., Aldrovandi G.M., Kutsch O., Shaw G.M. Dynamics of HIV-1 recombination in its natural target cells. Proc. Nat. Acad. Sci. U.S.A. 2004, 101(12):4204-4209.
27. Levy D.N., Refaeli Y., MacGregor R.R., Weiner D.B. Serum Vpr regulates productive infection and latency of human immunodeficiency virus type 1. Proc. Nat. Acad. Sci. U.S.A. 1994, 91(23):10873-10877.
28. Levy D.N., Refaeli Y., Weiner D.B. Extracellular Vpr protein increases cellular permissiveness to human immunodeficiency virus replication and reactivates virus from latency. J. Virol. 1995, 69(2):1243-1252.
29. Liang C., Zhang M., Sun S.C. beta-TrCP binding and processing of NF-kappaB2/p100 involve its phosphorylation at serines 866 and 870. Cell. Signal. 2006, 18(8):1309-1317.
30. Lum J.J., Cohen O.J., Nie Z., Weaver J.G., Gomez T.S., Yao X.J., Lynch D., Pilon A.A., Hawley N., Kim J.E., Chen Z., Montpetit M., Sanchez-Dardon J., Cohen E.A., Badley A.D. Vpr R77Q is associated with long-term nonprogressive HIV infection and impaired induction of apoptosis. J. Clin. Invest. 2003, 111(10):1547-1554.
31. Manches O., Fernandez M.V., Plumas J., Chaperot L., Bhardwaj N. Activation of the noncanonical NF-kappaB pathway by HIV controls a dendritic cell immunoregulatory phenotype. Proc. Nat. Acad. Sci. U.S.A. 2012, 109(35):14122-14127.
32. Mingyan Y., Xinyong L., De Clercq E. NF-kappaB: the inducible factors of HIV-1 transcription and their inhibitors. Mini-Rev. Med. Chem. 2009, 9(1):60-69.
33. Muller B., Tessmer U., Schubert U., Krausslich H.G. Human immunodeficiency virus type 1 Vpr protein is incorporated into the virion in significantly smaller amounts than gag and is phosphorylated in infected cells. J. Virol. 2000, 74(20):9727-9731.
34. Nabel G., Baltimore D. An inducible transcription factor activates expression of human immunodeficiency virus in T cells. Nature 1987, 326(6114):711-713.
35. Neumann M., Fries H., Scheicher C., Keikavoussi P., Kolb-Maurer A., Brocker E., Serfling E., Kampgen E. Differential expression of Rel/NF-kappaB and octamer factors is a hallmark of the generation and maturation of dendritic cells. Blood 2000, 95(1):277-285.
36. Paxton W., Connor R.I., Landau N.R. Incorporation of Vpr into human immunodeficiency virus type 1 virions: requirement for the p6 region of gag and mutational analysis. J. Virol. 1993, 67(12):7229-7237.
37. Postler T.S., Desrosiers R.C. The cytoplasmic domain of the HIV-1 glycoprotein gp41 induces NF-kappaB activation through TGF-beta-activated kinase 1. Cell Host Microbe 2012, 11(2):181-193.
38. Razani B., Reichardt A.D., Cheng G. Non-canonical NF-kappaB signaling activation and regulation: principles and perspectives. Immunol. Rev. 2011, 244(1):44-54.
39. Roux P., Alfieri C., Hrimech M., Cohen E.A., Tanner J.E. Activation of transcription factors NF-kappaB and NF-IL-6 by human immunodeficiency virus type 1 protein R (Vpr) induces interleukin-8 expression. J. Virol. 2000, 74(10):4658-4665.
40. Santoro M.G., Rossi A., Amici C. NF-kappaB and virus infection: who controls whom. EMBO J. 2003, 22(11):2552-2560.
41. Skaug B., Jiang X., Chen Z.J. The role of ubiquitin in NF-kappaB regulatory pathways. Annu. Rev. Biochem. 2009, 78:769-796.
42. Subbramanian R.A., Kessous-Elbaz A., Lodge R., Forget J., Yao X.J., Bergeron D., Cohen E.A. Human immunodeficiency virus type 1 Vpr is a positive regulator of viral transcription and infectivity in primary human macrophages. J. Exp. Med. 1998, 187(7):1103-1111.
43. Sun S.C. Non-canonical NF-kappaB signaling pathway. Cell Res. 2011, 21(1):71-85.
44. Tan J., Qiao W., Wang J., Xu F., Li Y., Zhou J., Chen Q., Geng Y. IFP35 is involved in the antiviral function of interferon by association with the viral tas transactivator of bovine foamy virus. J. Virol. 2008, 82(9):4275-4283.
45. Tristem M., Marshall C., Karpas A., Hill F. Evolution of the primate lentiviruses: evidence from vpx and vpr. EMBO J. 1992, 11(9):3405-3412.
46. Tristem M., Purvis A., Quicke D.L. Complex evolutionary history of primate lentiviral vpr genes. Virology 1998, 240(2):232-237.
47. Tungaturthi P.K., Sawaya B.E., Singh S.P., Tomkowicz B., Ayyavoo V., Khalili K., Collman R.G., Amini S., Srinivasan A. Role of HIV-1 Vpr in AIDS pathogenesis: relevance and implications of intravirion, intracellular and free Vpr. Biomed. Pharmacother. 2003, 57(1):20-24.
48. Varin A., Decrion A.Z., Sabbah E., Quivy V., Sire J., Van Lint C., Roques B.P., Aggarwal B.B., Herbein G. Synthetic Vpr protein activates activator protein-1, c-Jun N-terminal kinase, and NF-kappaB and stimulates HIV-1 transcription in promonocytic cells and primary macrophages. J. Biol. Chem. 2005, 280(52):42557-42567.
49. Wang J., Tan J., Guo H., Zhang Q., Jia R., Xu X., Geng Y., Qiao W. Bovine foamy virus transactivator BTas interacts with cellular RelB to enhance viral transcription. J. Virol. 2010, 84(22):11888-11897.
50. Wang J., Tan J., Zhang X., Guo H., Zhang Q., Guo T., Geng Y., Qiao W. BFV activates the NF-kappaB pathway through its transactivator (BTas) to enhance viral transcription. Virology 2010, 400(2):215-223.
51. Wang L., Mukherjee S., Jia F., Narayan O., Zhao L.J. Interaction of virion protein Vpr of human immunodeficiency virus type 1 with cellular transcription factor Sp1 and trans-activation of viral long terminal repeat. J. Biol. Chem. 1995, 270(43):25564-25569.
52. Yedavalli V.S., Shih H.M., Chiang Y.P., Lu C.Y., Chang L.Y., Chen M.Y., Chuang C.Y., Dayton A.I., Jeang K.T., Huang L.M. Human immunodeficiency virus type 1 Vpr interacts with antiapoptotic mitochondrial protein HAX-1. J. Virol. 2005, 79(21):13735-13746.
53. Zhou Y., Ratner L. Phosphorylation of human immunodeficiency virus type 1 Vpr regulates cell cycle arrest. J. Virol. 2000, 74(14):6520-6527.